Skip to Content

New Drug Approvals Archive - December 2002

See also: New Indications and Dosage Forms for December 2002

December 2002

Humira (adalimumab) Injection

Date of Approval: December 31, 2002
Company: Abbvie, Inc.
Treatment for: Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease -- Acute, Crohn's Disease -- Maintenance, Psoriasis, Juvenile Idiopathic Arthritis, Ulcerative Colitis, Hidradenitis Suppurativa, Uveitis

Humira (adalimumab) is a recombinant human IgGl monoclonal antibody specific for human tumor necrosis factor (TNF) indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, psoriasis, juvenile idiopathic arthritis, ulcerative colitis, hidradenitis suppurativa, and certain types of uveitis.

New Drug Approvals Archive

2018January, February, March, April, May, June, July, August, September, October

2017January, February, March, April, May, June, July, August, September, October, November, December

2016January, February, March, April, May, June, July, August, September, October, November, December

2015January, February, March, April, May, June, July, August, September, October, November, December

2014January, February, March, April, May, June, July, August, September, October, November, December

2013January, February, March, April, May, June, July, August, September, October, November, December

2012January, February, March, April, May, June, July, August, September, October, November, December

2011January, February, March, April, May, June, July, August, October, November, December

2010January, February, March, April, May, June, July, August, September, October, November, December

2009January, February, March, April, May, June, July, August, September, October, November, December

2008January, February, March, April, May, June, July, August, September, October, November, December

2007January, February, March, April, May, June, July, August, September, October, November, December

2006January, February, March, April, May, June, July, August, September, October, November, December

2005January, February, March, April, May, June, July, August, September, October, November, December

2004January, February, March, April, May, June, July, August, September, October, November, December

2003January, February, March, April, May, June, July, August, September, October, November, December

2002January, February, April, May, July, August, September, October, November, December

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Recently Approved

Talzenna Talzenna (talazoparib) is an oral poly ADP ribose polymerase (PARP) inhibitor indicated for the...
Yutiq Yutiq (fluocinolone acetonide) is a corticosteroid intravitreal implant indicated for the treatment...
Tegsedi Tegsedi (inotersen) is an antisense oligonucleotide inhibitor of the transthyretin (TTR) protein...
Revcovi Revcovi (elapegademase-lvlr) is a recombinant adenosine deaminase indicated for the treatment of...

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com Pill Reminder

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Oct 1st, 2018), Cerner Multum™ (updated Oct 2nd, 2018), Wolters Kluwer™ (updated Oct 2nd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.